Investors

Fresenius Medical Care, the world’s largest provider of dialysis products and services, is aware that patient data from some of the company’s dialysis centers in Serbia has been published by unauthorized persons.

Fresenius Medical Care, the world’s largest provider of dialysis products and services, today successfully placed bonds in two tranches with an aggregate volume of €1.25 billion.

9% revenue increase supported by growth in all regions; Positive earnings growth despite negative impact from COVID-19 pandemic; Solid cash-flow development; Financial targets for FY2020 confirmed